Archive - February 2018
Vertex secures US approval for Symdeko
Novartis nabs FDA approval for delayed MS drug
Former Anthem CEO Swedish joins Proteus Digital Health board of directors
NICE gives nod to plaque psoriasis drug Kyntheum
Pfizer files third-gen ALK inhibitor for lung cancer
CureVac snags new Gates Foundation backing for universal flu, malaria mRNA vaccine work
Light-activated cancer drugs without toxic side effects: fresh insight
Purdue pulls plug on opioid marketing